Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.
It's no surprise that campaigning for office is largely a matter of buying votes with unrealistic promises of largesse to be ...
7don MSN
About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they ...
Naltrexone (referred to as the "Ozempic of alcohol") is a drug that can help reduce alcohol and opioid cravings for people ...
Weight loss drugs like Ozempic and Wegovy cost an average of $1,116 per month or $13,397 per year if you pay full price. Find Cheap Health Insurance Quotes in Your Area Weight loss drugs cost $1 ...
2don MSN
Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic. If you had come across the ...
I've watched several people, including myself, go on weight loss adventures, whether through rigid diets, intense gym ...
As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback